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OBJECTIVE—Insulin resistance and other features of the met-
abolic syndrome have been causally linked to adipose tissue
macrophages (ATMs) in mice with diet-induced obesity. We
aimed to characterize macrophage phenotype and function in
human subcutaneous and omental adipose tissue in relation to
insulin resistance in obesity.
RESEARCH DESIGN AND METHODS—Adipose tissue was
obtained from lean and obese women undergoing bariatric
surgery. Metabolic markers were measured in fasting serum and
ATMs characterized by immunohistology, ﬂow cytometry, and
tissue culture studies.
RESULTS—ATMs comprised CD11c
CD206
 cells in “crown”
aggregates and solitary CD11c
CD206
 cells at adipocyte junc-
tions. In obese women, CD11c
 ATM density was greater in
subcutaneous than omental adipose tissue and correlated with
markers of insulin resistance. CD11c
 ATMs were distinguished
by high expression of integrins and antigen presentation mole-
cules; interleukin (IL)-1, -6, -8, and -10; tumor necrosis factor-;
and CC chemokine ligand-3, indicative of an activated, proinﬂam-
matory state. In addition, CD11c
 ATMs were enriched for
mitochondria and for RNA transcripts encoding mitochondrial,
proteasomal, and lysosomal proteins, fatty acid metabolism
enzymes, and T-cell chemoattractants, whereas CD11c
 ATMs
were enriched for transcripts involved in tissue maintenance and
repair. Tissue culture medium conditioned by CD11c
 ATMs, but
not CD11c
 ATMs or other stromovascular cells, impaired
insulin-stimulated glucose uptake by human adipocytes.
CONCLUSIONS—These ﬁndings identify proinﬂammatory
CD11c
 ATMs as markers of insulin resistance in human obesity.
In addition, the machinery of CD11c
 ATMs indicates they
metabolize lipid and may initiate adaptive immune responses.
Diabetes 59:1648–1656, 2010
T
he metabolic syndrome associated with obesity
is characterized by insulin resistance, hypergly-
cemia, hypertension, and dyslipidemia, revers-
ible by weight loss (1). Studies in obese mice
indicate that adipose tissue inﬂammation, centered on
macrophages recruited to and activated by an expanding
adipose tissue mass, is a mechanistic link between obesity
and insulin resistance. The density of adipose tissue
macrophages (ATMs) correlates with adipose tissue in-
ﬂammatory markers and insulin resistance (2), but, more
importantly, mice that lack the proinﬂammatory enzyme
IB kinase- in macrophages do not develop diet-induced
insulin resistance (3), and mice that lack the anti-inﬂam-
matory transcription factor peroxisome proliferator–acti-
vated receptor- in macrophages develop insulin resistance
(4,5).
Two ATM populations have been described in mice. In
lean animals, solitary “resident” ATMs predominate. These
ATMs have an “alternative” (M2) macrophage phenotype
characterized by increased expression of interleukin
(IL)-10 and arginase (6) and may facilitate adipogenesis
(7). Obese mice also exhibit “crown” macrophages aggre-
gated around necrotic adipocytes (8). These ATMs have
increased expression of the integrin CD11c and markers of
“classical” (M1) macrophages, including IL-6 and inducible
nitric oxide (NO) synthase (6,9,10). The phenotypic switch
from M2 to M1 could be an important determinant of
insulin resistance in obese mice because CD11c promoter–
dependent conditional deletion of ATMs improves insulin
sensitivity (11).
A role for ATMs in the pathophysiology of human insulin
resistance is less well established. As in mice, adipose
tissue of obese humans exhibits increased expression of
genes encoding proinﬂammatory cytokines (12) and con-
tains increased numbers of ATMs compared with adipose
tissue from lean control subjects (13,14). However, ATM
density, determined by histology or CD68 mRNA expres-
sion, was found to correlate weakly or not at all with
insulin resistance (15–17). In addition, the existence of M1
and M2 ATM subsets has not been conﬁrmed. A role for
ATMs in human insulin resistance is also confounded by
several differences between mice and humans. These
include increased expression of resistin (18) and reduced
expression of inducible NO synthase (19) and arginase
(20) in human macrophages and reduced expression of
CD11c by ATMs (21) and a relative paucity of crown
macrophages in human adipose tissue (17,21,22). To better
understand the role of ATMs in human obesity and insulin
resistance, we enumerated and characterized ATMs from
lean and obese women.
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Subjects and tissue. Initially, tissues were obtained from 29 Caucasian
women undergoing laparoscopic surgery for insertion or revision of a gastric
band. Subsequently, tissues were obtained from a further 89 Caucasian
women to conﬁrm initial ﬁndings and undertake mechanistic studies. Subcu-
taneous and omental adipose tissues were resected from the peri-umbilical
region and omentum near the Angle of His, respectively, placed in DMEM
(Sigma, Sydney, Australia) supplemented with 20 mmol/l HEPES (Sigma) and
transported to the laboratory within 2 h. Approval was given by the human
research and ethics committees of The Avenue Hospital and the Walter and
Eliza Hall Institute of Medical Research.
Biochemistry. Analyses were performed on fasting blood samples provided
within 3 months of surgery. Insulin resistance was determined using the
homeostasis model assessment (HOMA) 2 calculator (46). Adiponectin and
leptin Luminex assays (Linco Research, St. Charles, MO) and high–molecular
weight adiponectin enzyme-linked immunosorbent assays (Fujirebio, Japan)
were performed on sera collected immediately prior to anesthesia. Cytokine/
chemokine concentrations in cell culture supernatants were determined by
Luminex assays (Linco Research).
Immunohistochemistry. Formalin-ﬁxed 5-m adipose tissue sections were
dewaxed in xylene and boiled in antigen-unmasking solution (Vector, Sacra-
mento, CA) for 15 min. Frozen 12-m sections cut from adipose tissue
embedded in optimal cutting temperature (OCT) compound (Tissue-Tek,
Torrance, CA) were ﬁxed in acetone. Primary antibodies used were CD68
(PG-M1; Dako, Glostrup, Denmark), CD11c (563; Novocastra, Newcastle upon
Tyne, U.K.), CD206 (551135; BD Biosciences, Lane Cove, NSW, Australia), and
voltage-dependent anion channel (VDAC1) (ab14734; Abcam, Cambridge,
U.K.). For single-antibody stains, sections were treated with 1% H2O2 then
washed in PBS before overnight incubation with primary antibody. Antigen
signal was detected by further incubation with biotinylated anti-mouse IgG
antibody (Dako), followed by streptavidin–horseradish peroxidase (Vector)
and then DAB liquid (DAKO). For immunoﬂuorescence, anti-mouse Alexa
488 (Invitrogen, Carlsbad, CA), biotinylated anti-mouse IgG3 (BD Bio-
sciences), and streptavidin–Alexa 594 (Invitrogen) were used as secondary
antibodies. Images were obtained using an Axioskop2 microscope (Zeiss,
Munich, Germany) and AxioVision version 4.6 software (Zeiss). Oil red O
staining was performed on cells ﬁxed in formalin vapor by incubation in 0.6%
wt/vol Oil red O (Sigma) in 60% vol/vol isopropanol for 15 min followed by
counterstaining with hematoxylin.
Crowns were deﬁned as three or more CD68-positive cells surrounding an
adipocyte, and crown density was deﬁned as the number of crowns per
high-power ﬁeld. A minimum of four low-power (40) ﬁelds was counted on
two separate occasions by one observer (J.W.), blinded to the adipose tissue
donor. Mean adipocyte size in pixels was determined from three 100 ﬁelds
using ImageJ software (National Institutes of Health, Bethesda, MD).
Adipose tissue digestion and ﬂow cytometry. Adipose tissue was minced
with sterile scissors, centrifuged at 755g to remove blood cells, and digested
in DME/HEPES (10 ml/2 g) supplemented with 10 mg/ml fatty acid–poor BSA
(Calbiochem, San Diego, CA), 35 g/ml liberase blendzyme 3 (Roche, India-
napolis, IN), and 60 units/ml DNAse I (Sigma) in a 37° water bath. Samples
were minced every 5 min for 50 min then passed through a sterile strainer
before centrifuging at 612g. The stromovascular cell pellet was treated with
red cell lysis solution (155 mmol/l NH4Cl, 10 mmol/l KHCO3, and 90 mol/l
EDTA), applied to a 70-m ﬁlter, and suspended in ﬂuorescence-activated cell
sorting (FACS) buffer (PBS/1 mmol/l EDTA/5 mg/ml fatty acid–poor BSA). For
cytokine release and gene microarray experiments, stromovascular cells were
initially separated into CD14
 and CD14
 fractions with anti-CD14 magnetic
beads and MS separation columns (Miltenyi, North Ryde, NSW, Australia).
Flow cytometry was performed on a FACSAria (weekly coefﬁcient of
variation 	7%) and analyzed with FacsDiva version 6.0 software (BD Bio-
sciences). Cells were stained in the presence of 10% vol/vol ﬂuorochrome-
conjugated antibodies and suspended in FACS buffer containing 0.05 g/ml
propidium iodide. FSc-A/FSc-H and propidium iodide gates were used to
identify single, live cells. Fluorescence intensity was normalized by subtract-
ing the ﬂuorescence intensity of phycoerythrin (PE)-conjugated isotype
control antibody or of cells incubated in the absence of Mitotracker red. For
cell sorting, CD14
, CD14
, or stromovascular preparations were stained with
CD11c-allophycocyanin, CD14–ﬂuorescein isothiocyanate (FITC), CD45-PC7,
and CD206-PE antibodies. The purity of all isolations was 
90% (supplemen-
tal Fig. 2, available at http://diabetes.diabetesjournals.org/cgi/content/full/
db09-0287/DC1). All antibodies were obtained from BD Biosciences, with the
exception of TLR2-PE and TLR4-PE (BioLegend, San Diego, CA), CCR2-PE
(R&D Systems, Minneapolis, MN), and CD14-PC7 and CD45-PC7 (Beckman
Coulter, Paris, France). Mitotracker red mitochondrial dye was from Molec-
ular Probes (Eugene, OR).
Conditioned medium. For measurement of secreted cytokines, ATMs were
sorted from the CD14
 stromovascular population, suspended at 20,000 in 100
l RPMI medium (Sigma) supplemented with 10% FCS (Thermo Electron,
Melbourne), and cultured 20 ng/ml lipopolysaccharide (LPS) in 96-well
ﬂat-bottom tissue culture plates (BD Labware, Franklin Lakes, NJ) for 24 h.
Cell viability after 24 h, determined by ethidium bromide/acridine orange
uptake (BDH Chemicals, Poole, U.K.), was 60–90%. To condition medium to
screen for inhibition of insulin action, individual cell types were sorted
directly from the stromovascular population, suspended in serum-free F3
medium (DME/HAMF12 containing 8 mg/l biotin, 4 mg/l pantothenate, 2 mg/l
gentamicin, 2 mmol/l Glutamax, 10 mg/l transferrin, 200 pmol/l triiodothyro-
nine, and 100 nmol/l hydrocortisone; all from Sigma), and cultured in 96-well
round-bottom plates for 48 h.
Insulin-stimulated glucose uptake. Freshly isolated human adipocytes
rapidly lose viability and sensitivity to insulin. The human Simpson-Golabi-
Behmel syndrome (SGBS) preadipocyte (PA) cell line, which is neither
transformed nor immortalized, can be induced to differentiate in vitro,
providing a unique tool for the study of human adipocytes and their response
to insulin (47). SGBS PAs were ﬁrst differentiated in 96-well plates as
previously described (47) and then cultured for 48 h in serum-free F3 medium
conditioned (20% vol/vol) by medium from total stromovascular cells,
CD11c
CD206
 ATMs, CD11c
 ATMs, lymphocyte (LYM), or PA cells. After
48 h, adipocyte morphology and lactate dehydrogenase (LDH) activity of the
supernatant was not signiﬁcantly different between groups. Adipocytes were
then washed in Krebs-Ringer phosphate (KRP) buffer (136 mmol/l NaCl, 4.5
mmol/l KCL, 1.25 mmol/l CaCl2, 1.25 mmol/l MgCl2, 0.6 mmol/l Na2HPO4, 0.4
mmol/l NaH2PO4, 10 mmol/l HEPES, and 0.1% BSA), incubated at 37°C for 20
min in 40 l KRP with or without insulin before addition of 10 l KRP
containing 0.25 mmol/l unlabeled 2-deoxyglucose and 0.1 Ci tritiated 2-de-
oxyglucose (Perkin Elmer) for a further 10 min. Cells were then washed with
ice-cold PBS containing 80 mg/l phloretin (Sigma) before lysis in 0.1 mol/l
NaOH, transfer into UltimaGold scintillant (Perkin Elmer), and -scintillation
counting. Counts (cpm) were corrected for cell-free blanks. The intra-assay
coefﬁcient of variation for replicate control wells was 5–18%.
Quantitative PCR and gene microarray. RNA was prepared from cell
pellets using a Picopure RNA kit (Arcturus, Oxnard, CA). DNA was prepared
by proteinase K digestion and ethanol precipitation. Primer sequences are
shown (supplemental Table 2). Ampliﬁcation efﬁciencies of primer pairs were
not signiﬁcantly different over the concentration ranges measured. For
RT-PCR, total RNA was reverse transcribed using Superscript III (Invitrogen)
and ampliﬁed on an ABI Prism 7700 platform using the Sybergreen reporter
(Qiagen, Valencia, CA). Gene expression relative to -actin was determined
using the comparative CT method.
Gene microarray of CD11c
 and CD11c
CD206
 ATMs was performed
using 50 ng total RNA and human WG-6 v2 bead chips (Illumina, San Diego,
CA). Microarray analysis used the lumi, limma, and annotation packages of
Bioconductor (48). Expression data were background corrected using nega-
tive control probes followed by a variance-stabilizing transformation (49) and
quantile normalization. Gene-wise linear models were ﬁtted to determine
differences between cell populations, taking into account subject-to-subject
variability. Signiﬁcant differentially expressed genes were identiﬁed using
empirical Bayes moderated t tests and a false discovery rate of 5% (50).
Functional annotation clustering analysis (25) of differentially expressed
genes was performed online (www.david.abcc.ncifcrf.gov/home.jsp) using
default settings.
Statistical analysis. Statistical analyses were performed with Prism version
5.0a software for Macintosh (Graphpad, San Diego, CA). Pairs of groups were
compared by the Mann-Whitney test or Wilcoxon matched-pairs test, as
appropriate. Multiple groups were analyzed by ANOVA, with Newman-Keuls
posttest comparisons of group pairs. Correlation was determined by Spear-
man rank-log test. P 	 0.05 was considered signiﬁcant.
RESULTS
Crown ATMs express CD11c. Subcutaneous and omen-
tal adipose tissue was obtained from obese women (BMI
range 39–56 kg/m
2) undergoing bariatric surgery. In tissue
sections stained for the monocyte/macrophage marker
CD68, the majority of monocytes/macrophages appeared
as slender, “resident” cells at the junctions of two or more
adipocytes (Fig. 1A). Less frequently, ATMs surrounded
adipocytes in heterogeneously distributed crown aggre-
gates. Crown ATMs were larger, ovoid cells that occasion-
ally coalesced to form syncytial giant cells (Fig. 1A).
Scattered monocytes were also observed within arterioles
J.M. WENTWORTH AND ASSOCIATES
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lymphoid aggregates. Serial sections were stained for
CD11c, a marker of mouse proinﬂammatory ATMs (6).
CD11c was predominantly expressed by crown ATMs,
although many resident ATMs showed weak CD11c stain-
ing (Fig. 1B). Preferential expression of CD11c by crown
ATMs was conﬁrmed by ﬂuorescence microscopy (Fig.
1C). CD11c immunoreactivity was exclusive to CD68

cells. Sections were also stained for CD206, a marker of
ATMs that does not stain monocytes (21). By light micros-
copy, CD206 staining intensity was similar in resident and
crown ATMs (Fig. 1D), but by ﬂuorescence microscopy
staining was weaker in crown ATMs (Fig. 1E).
Analysis of crown and resident ATMs by ﬂow cytom-
etry. To analyze ATMs in more detail, ﬂow cytometry was
performed on stromovascular cells isolated from digested
subcutaneous and omental adipose tissue. Because CD68
is an intracellular antigen, anti-CD14 and -CD45 antibodies
were used to identify ATMs, PAs (23), and CD14
CD45

cells; the latter were designated LYM because most also
expressed the T-cell marker, CD3 (Fig. 2A). By immuno-
histochemistry (Fig. 2B), CD68 expression was speciﬁc to
ATMs. We determined the phenotypes of stromovascular
cells with antibodies to CD11c and CD206 (Fig. 2C). CD206
was expressed by all CD11c
 ATMs and not by PAs or
LYM. However, only a subset of CD11c
 ATMs expressed
CD206. As with ﬂuorescence microscopy (Fig. 1E), these
CD11c
 ATMs had a lower CD206 ﬂuorescence intensity
than CD11c
 ATMs. In addition, staining with Oil red O
revealed that they contained more intracellular lipid
than CD11c
 ATMs (Fig. 2D). CD11c
CD206
 ATMs
had a similar proﬁle to blood monocytes (Fig. 2C).
Together with immunohistochemistry, ﬂow cytom-
etry demonstrated that CD11c
, CD11c
CD206
, and
CD11c
CD206
 ATM populations represent, respec-
tively, resident ATMs, crown ATMs, and adipose tissue
monocytes. While CD11c
CD206
 cells were rarely
observed in adipose tissue sections (Fig. 1E), they were
readily detected by ﬂow cytometry (Fig. 2C). In addi-
tion, due to the presence of lymphoid aggregates, omen-
tal samples sometimes contained very high numbers of
LYM cells and CD11c
CD206
 ATMs.
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FIG. 1. Immunohistochemistry of subcutaneous adipose tissue in obe-
sity. A: Formalin-ﬁxed adipose tissue section stained for CD68 showing
a crown (*) and several resident ATMs (arrowheads). B: Serial section
stained for CD11c showing crown ATMs preferentially expressing
CD11c. C: Formalin-ﬁxed adipose section stained for CD11c and CD68
or with nonspeciﬁc isotype control antibodies conﬁrming that crown
ATMs (upper panel) but not resident ATMs (middle panel) express
CD11c. D: Frozen adipose tissue section stained for CD206 showing a
crown (*) and several resident ATMs. E: Frozen section stained for
CD206 and CD11c (upper panel) or with isotype control antibodies
(lower panel) showing crown ATMs expressing both CD11c and CD206
but resident ATMs expressing only CD206. Scale bar in all images  50
m. (A high-quality digital representation of this ﬁgure is available in
the online issue.)
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FIG. 2. Flow cytometry of subcutaneous adipose tissue stromovascular
cells. A: After excluding doublets and dead cells, a CD14 versus CD45
contour plot identiﬁed three stromovascular cell populations (PAs,
LYMs, and ATMs). B: Cytospins of each population stained for CD68
conﬁrmed that the CD14
CD45
 population represents ATMs. Scale
bar  20 m. C: Flow cytometry phenotype of gated PA, LYM and ATM
populations stained for CD11c and CD206 reveals that PA cells do not
express either marker, while a minority of LYM cells express low levels
of CD11c. ATM cells could be separated into three distinct subpopula-
tions when stained for CD11c and CD206; one of these, CD11c
CD206

ATMs, had a similar phenotype to blood monocytes (MONO). Back-
ground staining by isotype control antibodies is indicated by gray lines.
D: CD11c
CD206
 and CD11c
 ATMs were isolated by ﬂow cytometry
cell sorting and stained with Oil red O. Representative images show
CD11c
CD206
 ATMs contain more lipid than CD11c
 ATMs. Scale
bar  10 m. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
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determine the relationship between ATM populations and
insulin resistance, ATM density was quantitated in subcu-
taneous and omental adipose tissue from three groups of
women: formerly obese (FOb), obese (Ob), and obese with
metabolic syndrome (ObMS) (Table 1). The Ob and ObMS
groups were comparable in age and BMI, two independent
determinants of ATM density in humans (15,17). Histolog-
ically, in both adipose tissue depots, crown ATM density
was usually zero in FOb and higher in ObMS than Ob (Fig.
3A). In addition, in ObMS, crown density was higher in
subcutaneous than omental adipose tissue. The differ-
ences between Ob and ObMS adipose tissue were not
explained by differences in adipocyte size (Fig. 3B).
ATM density was then measured by ﬂow cytometry,
expressed as percent viable cells within the stromovascu-
lar population. None of the omental samples from all 29
women studied contained lymphoid aggregates. Crown
density and CD11c
CD206
 ATM density were signiﬁ-
cantly correlated (Fig. 3C), validating ﬂow cytometric
assessment. In both subcutaneous and omental adipose
tissue, obesity was associated with a signiﬁcant increase
in densities of CD11c
CD206
 (monocyte) (not shown),
CD11c
CD206
 (crown) (Fig. 3D), and CD11c
 (resident)
(Fig. 3E) ATMs. Insulin resistance was associated with
increased numbers of CD11c
CD206
 ATMs (Fig. 3D) but
similar numbers of CD11c
 ATMs (Fig. 3E). Accordingly,
the CD11c
CD206
/CD11c
 ATM ratio was greater in
ObMS compared with Ob subjects (Fig. 3F). Although the
differences in subcutaneous and omental ATM densities
between FOb, Ob, and ObMS were qualitatively similar,
crown and CD11c
CD206
 ATM densities were lower in
omental adipose tissue. LYM and PA densities were in-
creased and decreased, respectively, in obesity but were
not signiﬁcantly different between Ob and ObMS (not
shown).
In the 24 obese women, the CD11c
CD206
/CD11c

ATM ratio correlated signiﬁcantly with insulin resistance
(HOMA of insulin resistance [HOMA-IR]) (Fig. 3G). In
contrast, there was no correlation between HOMA-IR and
CD11c
 ATM density, age, or BMI. A similar and more
signiﬁcant correlation between the HOMA-IR and
CD11c
CD206
/CD11c
 ATM ratio was conﬁrmed in an-
other 89 obese women, particularly in subcutaneous adi-
pose tissue (Fig. 3H). These results, together with the
comparison of ATM densities between the Ob and ObMS
above, implicate CD11c
CD206
 ATMs in the pathogene-
sis of insulin resistance.
Crown ATMs have an M1 surface phenotype. To
further characterize ATMs, cell surface marker expression
was determined by ﬂow cytometry. Results were similar
for subcutaneous and omental ATMs and are shown
therefore only for subcutaneous ATMs and blood mono-
cytes (Fig. 4). Expression of the innate immune molecules
CD14, Toll-like receptor (TLR)2, TLR4, and C-C receptor
(CCR)2 was highest on blood monocytes, with variable
expression by ATM subtypes. Expression of integrins was
highest on blood monocytes and progressively declined
from CD11c
CD206
 to CD11c
CD206
 to CD11c

ATMs. In contrast, CD11c
 ATMs expressed the highest
levels of CD163, a marker of alternative macrophage
activation (24), and CD34, a marker of adipogenic/angio-
genic ATMs (7). Finally, CD11c
CD206
 ATMs expressed
the highest levels of CD45, the antigen-presenting mole-
cules CD1c and HLA-DR, and the T-cell costimulatory
molecule CD86. This was most striking for CD1c, which is
known to bind and present lipid antigens.
Crown ATMs are the major source of proinﬂamma-
tory cytokines and chemokines. To determine their
potential contribution to adipose tissue inﬂammation,
stromovascular cells were isolated and cultured overnight,
and secreted cytokines and chemokines were measured in
TABLE 1
Clinical characteristics of the FOb, Ob, and ObMS women studied*
FOb (n  5)
Ob (n  12) ObMS (n  12) Obese Lean
Age (years) 35  5 (20–52) 39  6 (21–54)† 46  2 (28–55) 47  3 (30–61)†
BMI (kg/m
2) 40  3 (34–46) 26  1 (23–30)‡ 46  1 (39–53) 44  1 (39–56)
Waist-to-hip ratio 0.85  0.01 (0.82–0.87) 0.80  0.01 (0.76–0.82)‡ 0.85  0.02 (0.75–0.98) 0.93  0.02 (0.86–1.1)‡§
Fasting glucose
(mmol/l) 4.6  0.3 (3.8–5.5) 4.5  0.2 (4.1–5.0) 5.0  0.1 (4.7–5.5) 6.4  0.5 (5.0–10.0)†§
Fasting insulin
(mIU/l) 12  1 (8–15) 4  0.4 (3–5)‡ 13  2 (4–26) 24  3 (13–47)§
HOMA-IR 1.5  0.2 (1.0–2.0) 0.46  0.05 (0.4–0.6)‡ 1.6  0.3 (0.5–3.3) 3.2  0.4 (1.7–6.3)‡§
Fasting triglycerides
(mmol/l) 1.4  0.3 (0.8–2.5) 1.0  0.2 (0.7–1.7) 1.4  0.1 (0.6–2.5) 2.4  0.4 (1.1–6.2)†
HDL (mmol/l) 1.5  0.1 (1.4–1.7) 1.4  0.1 (1.1–1.7) 1.5  0.1 (1.2–2.0) 1.1  0.1 (0.7–1.7)†
Alanine transaminase
(IU/l) 25  7 (12–53) 17  2 (14–22) 20  2 (14–35) 44  10 (16–144)§
Hypertension 1/5 1/5 2/12 5/9
Type 2 diabetes 0/5 0/5 0/12 3/12
Metabolic syndrome
score 1.4  0.2 (1–2) 0.2  0.2 (0–1)‡ 1.3  0.5 (1–2) 3.4  0.7 (3–5)‡§
Fasting adiponectin
(mg/l) NP 19  3 (11–26) 13  1 (8–25) 11  1 (7–22)
Fasting HMW
adiponectin (mg/l) NP 15  3 (7–25) 9  1 (5–21) 7  1 (4–15)
Fasting leptin (mg/l) NP 47  5 (35–61) 64  7 (34–100) 65  9 (34–130)
Continuous data are means  SE (range). *Metabolic syndrome is deﬁned as three or more of the following: waist 
88 cm, blood pressure

130/85 mmHg, fasting glucose 
5.6 mmol/l, HDL 	1.2 mmol/l, and triglycerides 
1.7 mmol/l. †P 	 0.05 cf obese FOb; ‡P 	 0.005 cf obese
FOb; §P 	 0.005 cf Ob; P 	 0.05 cf Ob. NP, not performed.
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CD206
 adipose
tissue monocytes could be isolated for these experiments.
ATMs from subcutaneous adipose tissue of three different
donors secreted at least 50-fold–higher amounts of IL-1,
IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-, and CCL3
compared with PA and LYM populations. In each donor,
comparison of the two ATM subtypes revealed that un-
stimulated CD11c
CD206
 ATMs secreted more IL-1,
IL-6, IL-8, IL-10, TNF-, and CCL3 than CD11c
 ATMs,
with IL-8 most highly and IL-10 most differentially secreted
(Fig. 5). LPS induced a nonselective increase in cytokine/
chemokine secretion by both ATM subtypes. No clear
differences in cytokine/chemokine secretion were de-
tected between subcutaneous and omental ATMs (data not
shown).
Crown ATMs are enriched for mitochondria and T-
cell chemoattractants. CD11c
CD206
 and CD11c

ATM transcriptomes were compared by microarray. RNA
was prepared from subcutaneous ATMs isolated from six
obese women. A total of 3,825 differentially expressed
genes were identiﬁed at a false discovery rate of 5%
(supplemental Table 1). Genes encoding CD1c, CD11a,
CD11c, CD49d, CD86, CD163, and HLA-DR were differen-
tially expressed in a pattern consistent with the ﬂow
cytometry ﬁndings. In addition, differential expression of
CD11c (ITGAX), the fatty acid metabolism genes APOE
and FABP4, and the collagen genes COL1A2 and COL6A3
was validated by RT-PCR in independently prepared ATMs
(supplemental Fig. 1).
Functional annotation clustering analysis (25), compar-
ing the 1,756 genes upregulated in CD11c
CD206
 ATMs
to all human genes, revealed a striking enrichment for
genes encoding mitochondrial proteins. It was then dem-
onstrated that CD11c
CD206
 ATMs contain greater num-
bers of mitochondria, by immunohistochemical staining
for the mitochondrial VDAC1 (Fig. 6A) and by determining
mitochondrial DNA copy number in sorted stromovascular
cell populations (Fig. 6B). Staining with Mitotracker red
demonstrated that CD11c
CD206
 ATMs, together with
PAs, have the highest mitochondrial activity within the
stromovascular population (Fig. 6C). Clustering analysis
also revealed that CD11c
CD206
 ATMs were enriched
for transcripts encoding glucose and fatty acid metabolism
proteins, integrins, proteosomal and lysosomal proteins,
and T-cell activation proteins. In contrast, of 2,069 genes
upregulated in CD11c
 ATMs, scavenger receptors, the
transforming growth factor- family of cytokines, compo-
nents of the extracellular matrix, and platelet-derived
growth factor- were overrepresented.
Crown ATM-conditioned medium inhibits insulin ac-
tion. To determine whether products of ATMs could
inhibit insulin action, insulin-stimulated glucose uptake by
human SGBS adipocytes was measured in the presence of
20% vol/vol serum-free medium conditioned by stromovas-
cular cells or ﬂow-sorted CD11c
CD206
 ATMs, CD11c

ATMs, LYM, or PA cells. In four independent experiments,
medium conditioned by CD11c
CD206
 crown ATMs con-
sistently inhibited glucose uptake at 1 and 10 nmol/l
insulin (Fig. 7).
DISCUSSION
This study documents, for the ﬁrst time, two ATM subsets
in human obesity with distinct anatomical and functional
properties. CD11c
CD206
 ATMs localize to crowns and
express higher levels of integrins, antigen presentation
molecules, and proinﬂammatory cytokines and one or
more secreted factors that impair insulin action. These are
features of classically activated macrophages (24,26), yet
CD11c
CD206
 ATMs also have features of alternatively
activated macrophages, namely high mitochondrial copy
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FIG. 3. A and B: ATM quantitation in subcutaneous and omental
adipose obtained from FOb, Ob, and ObMS women. Crown density and
mean adipocyte size determined by histology. C: Signiﬁcant correlation
between histological and ﬂow cytometry measures of crown ATM
density. D and E: CD11c
CD206
 (crown) and CD11c
 (resident) ATM
densities determined by ﬂow cytometry. F: The CD11c
CD206
/
CD11c
 ratio is increased in ObMS women, conﬁrming enrichment of
crown ATMs in the metabolic syndrome. G and H: Relationship be-
tween insulin resistance and CD11c
CD206
/CD11c
 ratio in subcuta-
neous and omental adipose in the initial cohort of 24 obese women and
in a subsequent cohort of 89 obese women. *, **, ***P < 0.05, 0.005,
0.0005, respectively (Mann Whitney t test).
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both basally and in response to LPS (24,28). CD11c

ATMs, on the other hand, occur as solitary cells and
express high levels of scavenger receptors and genes
implicated in tissue maintenance and repair. These are
features of alternatively activated macrophages (24).
CD11c
 ATMs also express higher levels of CD34, a
marker of ATMs within angiogenic cell clusters (7), as well
as platelet-derived growth factor-, a putative mitogen for
adipocyte stem cells (29), implying a role for CD11c

ATMs in adipogenesis. Thus, the M1/M2 paradigm of
mouse CD11c
/CD11c
 ATMs (6) may not be entirely
applicable to humans, as previously suggested (21).
Causality is virtually impossible to establish in humans
but, by analogy with mice in which CD11c
 macro-
phages or key macrophage genes have been targeted
(3–5,11), proinﬂammatory ATMs may have a primary
role in mediating insulin resistance. This is supported by
the relationship between the CD11c
CD206
/CD11c

ATM ratio and insulin resistance, the overall proinﬂam-
matory proﬁle of CD11c
CD206
 ATMs, and their abil-
ity to impair insulin action in our studies.
CD11c
CD206
 ATMs and/or cells with which they
could interact, such as T-cells, may release speciﬁc
factor(s) that act locally in adipose tissue and/or sys-
temically in key target organs such as liver, muscle, and
pancreas.
In age- and BMI-matched obese women, insulin resis-
tance was associated with an increased CD11c
CD206

ATM density and CD11c
CD206
/CD11c
 ATM ratio; in
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 ATM density was similar in subcutane-
ous and omental adipose tissue. Because CD11c
CD206

ATMs are a minor ATM subpopulation, it is not surprising
that previous studies found no association between total
ATM density and insulin resistance after correcting for
age, sex, and BMI (12,15–17). Our ﬁndings highlight the
importance of correcting for clinical heterogeneity and
quantitating the CD11c
CD206
 ATM subpopulation and
are consistent with a recent report (30) that crown mac-
rophage density in subcutaneous abdominal adipose tis-
sue correlated with insulin resistance in an obese,
predominately female population. Crown aggregate and
CD11c
CD206
 ATM density was lower in omental than
subcutaneous adipose tissue, implying that the latter is an
important determinant of insulin resistance, but this is at
odds with clinical studies that show that visceral adipose
tissue correlates better with insulin resistance (31). How-
ever, it is consistent with the greater size of subcutaneous
versus omental adipocytes and with a recent study in lean
and obese men that found subcutaneous, not visceral, fat
mass correlated with insulin resistance (32) and would
support the view (33) that visceral adiposity is a conse-
quence rather than a cause of insulin resistance. On the
other hand, immunohistochemistry with antibodies to
HAM56 and CD40, although semiquantitative, identiﬁed a
higher crown ATM density in omental adipose tissue of
obese men and women (15,34). This difference may be
methodological or explained by our exclusive study of
women or other differences in the study populations.
The relatively high secretion of IL-8 by CD11c
CD206

ATMs raises the possibility that CD11c
 ATM–derived IL-8
could promote metabolic complications of obesity, consis-
tent with earlier reports that serum IL-8 is increased in
obesity and type 2 diabetes (35,36) and that adipocytes are
not the predominant source of adipose tissue–derived IL-8
(37,38). While IL-8 is a potent neutrophil chemoattractant
(39), neutrophils were not evident on tissue sections or in
stromovascular preparations, suggesting another role for
CD11c
 ATM–derived IL-8. Further investigation of IL-8 in
human obesity will require speciﬁc antagonists, as homo-
logues of human IL-8 and its receptor CXCR1 are absent in
mice and rats (39).
Phenotyping of ATMs revealed a progressive decrease
in expression of integrins from blood monocytes to
CD11c
CD206
, CD11c
CD206
, and CD11c
 ATMs and
absent expression of the CCL2 chemokine receptor CCR2
on CD11c
 ATMs. This suggests a developmental pathway
from blood monocytes to resident ATMs, in accord with
mouse studies reporting that ATMs are derived mostly
from blood (10,13,14) and that blockade of monocyte
recruitment to adipose tissue with a CCL2 receptor antag-
onist (40) or by genetic ablation of CD49d (41) protects
mice against metabolic complications of obesity. Our
ﬁndings indicate that, in addition to CCR2 antagonists,
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CD31, or CD49d might also be therapeutic in this setting.
By microarray, CD11c
CD206
 ATMs were enriched for
lipid-rich vacuolar and mitochondrial RNAs and tran-
scripts encoding the lipid-binding proteins APOE and
FABP4 and enzymes for fatty acid metabolism. This proﬁle
is consistent with a role for CD11c
CD206
 ATMs in
converting potentially toxic lipid from dead adipocytes
into nontoxic lipoproteins for disposal from adipose tissue
into the circulation (8). CD11c
CD206
 ATMs were also
enriched for transcripts encoding components of the lyso-
some and proteasome and for proteins implicated in T-cell
attraction and activation. These features, together with
their proinﬂammatory phenotype, raise the possibility that
CD11c
CD206
 ATMs could initiate adaptive immune
responses to adipose tissue antigens, analogous to presen-
tation of oxidized LDL to T-cells by CD1 on foamy macro-
phages in atherosclerotic lesions (42). Recent studies
(43–45) in obese mice implicate antigen-speciﬁc adipose
tissue T-cells in insulin resistance and suggest that cross-
talk between T-cells and CD11c
CD206
 ATMs could
promote insulin resistance and perhaps other complica-
tions of obesity in humans. Of the few genes deﬁnitely
associated with insulin resistance in obesity identiﬁed
from genome-wide scans, peroxisome proliferator–acti-
vated receptor- was the only one overrepresented in
CD11c
CD206
 ATMs.
In summary, we characterize distinct CD11c
 and
CD11c
 subsets of human ATMs and present evidence that
CD11c
CD206
 ATMs form crowns, are enriched in the
adipose tissue of insulin-resistant women, are proinﬂamma-
tory, and impair insulin action. It will be important to
determine whether CD11c
CD206
 ATMs are also associ-
ated with features of the metabolic syndrome in other ethnic
groups and in men, whose ATM density is reported to be
higher than that of BMI-matched women (15). Finally, iden-
tifying the factors elaborated by CD11c
CD206
 ATMs that
impair insulin action may lead to novel anti-inﬂammatory
therapies for the complications of obesity.
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